Colgate-Palmolive Company
Oral Care Composition Containing Cetylpyridinium Tetrachlorozincate

Abstract:

Disclosed herein are oral care compositions comprising cetylpyridinium tetrachlorozincate for use in inhibiting growth of Streptococcus mutans in the oral cavity of a subject. In some embodiments, cetylpyridinium tetrachlorozincate is present in an amount of from 0.0001% to 1%, e.g., from 0.0001% to 0.009%, by weight of the composition.